WAKAMOTO PHARMACEUTICAL CO.,LTD. 4512Short Interest
No institution currently reports a short position of 0.5% or more in WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512). The last disclosure was on 2026-07-22 (Daiwa Securities Co. Ltd., 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
234 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 12 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2021-03-29 |
|---|---|
| Latest disclosure | 2026-07-22 (Daiwa Securities Co. Ltd., 0.49%) |
| Reporting institutions | 12 firms (234 reports) |
| Peak estimated short interest | 4.83% (2021-07-15, 6 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Individual
- Morgan Stanley MUFG Securities Co., Ltd.
- UBS AG
- Daiwa Securities Co. Ltd.
- Credit Suisse AG
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2021-07-19 | ExodusPoint Capital Management Singapore, Pte. Ltd. | Position 173,800 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2025-10-20 | Barclays Capital Securities Ltd | Position 171,277 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2026-07-22 | Daiwa Securities Co. Ltd. | Position 171,700 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2023-01-19 | Nomura International plc | Position 170,200 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2022-02-25 | Credit Suisse AG | Position 170,600 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2025-08-15 | Morgan Stanley MUFG Securities Co., Ltd. | Position 169,456 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2021-09-03 | JPM Securities Japan Co Ltd. | Position 170,162 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2024-01-31 | GOLDMAN SACHS INTERNATIONAL | Position 168,481 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2022-02-16 | UBS AG | Position 167,100 shares | Ratio 0.47% | ▼0.11% | Below 0.5% |
| 2024-10-09 | Individual | Position 139,100 shares | Ratio 0.39% | ▼0.23% | Below 0.5% |
| 2022-10-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 126,200 shares | Ratio 0.36% | ▼0.25% | Below 0.5% |
| 2022-05-03 | JANE STREET GLOBAL TRADING, LLC | Position 104,200 shares | Ratio 0.29% | ▼0.30% | Below 0.5% |
Disclosure History 234 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-07-22 | Daiwa Securities Co. Ltd. | Position 171,700 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2026-07-10 | Daiwa Securities Co. Ltd. | Position 205,300 shares | Ratio 0.58% | ▼0.06% | — |
| 2026-07-03 | Daiwa Securities Co. Ltd. | Position 225,600 shares | Ratio 0.64% | ▼0.14% | — |
| 2026-06-24 | Daiwa Securities Co. Ltd. | Position 274,200 shares | Ratio 0.78% | ▼0.08% | — |
| 2026-06-17 | Daiwa Securities Co. Ltd. | Position 303,000 shares | Ratio 0.86% | ▼0.04% | — |
| 2026-06-10 | Daiwa Securities Co. Ltd. | Position 316,500 shares | Ratio 0.90% | ▲0.09% | — |
| 2026-06-03 | Daiwa Securities Co. Ltd. | Position 283,200 shares | Ratio 0.81% | ▲0.11% | — |
| 2026-05-28 | Daiwa Securities Co. Ltd. | Position 246,400 shares | Ratio 0.70% | ▲0.02% | — |
| 2026-05-27 | Daiwa Securities Co. Ltd. | Position 238,300 shares | Ratio 0.68% | ▲0.18% | — |
| 2026-05-26 | Daiwa Securities Co. Ltd. | Position 177,300 shares | Ratio 0.50% | ▲0.09% | — |
| 2025-10-20 | Barclays Capital Securities Ltd | Position 171,277 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2025-10-14 | Barclays Capital Securities Ltd | Position 186,377 shares | Ratio 0.53% | ▲0.12% | — |
| 2025-08-15 | Morgan Stanley MUFG Securities Co., Ltd. | Position 169,456 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2025-08-08 | Morgan Stanley MUFG Securities Co., Ltd. | Position 203,576 shares | Ratio 0.58% | ▼0.03% | — |
| 2025-08-07 | Barclays Capital Securities Ltd | Position 172,077 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2025-08-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 214,776 shares | Ratio 0.61% | ▲0.02% | — |
| 2025-08-06 | Barclays Capital Securities Ltd | Position 191,577 shares | Ratio 0.54% | ▲0.06% | — |
| 2025-08-06 | Morgan Stanley MUFG Securities Co., Ltd. | Position 206,476 shares | Ratio 0.59% | ▼0.01% | — |
| 2025-08-05 | Barclays Capital Securities Ltd | Position 167,577 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2025-08-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 209,076 shares | Ratio 0.60% | ▲0.19% | — |
| 2025-07-29 | Barclays Capital Securities Ltd | Position 178,977 shares | Ratio 0.51% | ▲0.03% | — |
| 2025-07-25 | Barclays Capital Securities Ltd | Position 169,877 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2025-07-24 | Barclays Capital Securities Ltd | Position 175,577 shares | Ratio 0.50% | ▲0.01% | — |
| 2025-07-23 | Barclays Capital Securities Ltd | Position 172,477 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2025-07-18 | Barclays Capital Securities Ltd | Position 183,477 shares | Ratio 0.52% | ▲0.03% | — |
| 2025-07-17 | Barclays Capital Securities Ltd | Position 172,977 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2025-07-16 | Barclays Capital Securities Ltd | Position 174,477 shares | Ratio 0.50% | ▲0.03% | — |
| 2025-07-08 | Barclays Capital Securities Ltd | Position 165,477 shares | Ratio 0.47% | ▼0.07% | Below 0.5% |
| 2025-07-02 | Barclays Capital Securities Ltd | Position 191,377 shares | Ratio 0.54% | ▲0.08% | — |
| 2025-06-27 | Barclays Capital Securities Ltd | Position 163,077 shares | Ratio 0.46% | ▼0.04% | Below 0.5% |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |